A systematic review of combination step III opioid therapy in cancer pain: An EPCRC opioid guideline project

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Palliative Medicine

• Publication date

  2011-06-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0269216310392101PMID 21708862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opioid-induced hyperalgesia: a clinical challenge.

  2010cited by this paper
• Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.

  2009cited by this paper
• Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.

  2008cited by this paper
• Opioid-induced hyperalgesia: fact or fiction?

  2008cited by this paper
• Agonist-Specific Regulation of μ-Opioid Receptor Desensitization and Recovery from Desensitization

  2008cited by this paper
• Sustained‐release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

  2008cited by this paper
• Differences between and combinations of opioids re-visited

  2008cited by this paper
• Differential effect of opioids in patients with chronic pancreatitis: An experimental pain study

  2007cited by this paper
• Postoperative Intravenous Morphine Consumption, Pain Scores, and Side Effects with Perioperative Oral Controlled-Release Oxycodone After Lumbar Discectomy

  2007cited by this paper
• The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it?

  2006cited by this paper
• [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].

  2005cited by this paper
• Co-administration of oxycodone and morphine and analgesic synergy re-examined.

  2005cited by this paper
• Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

  2004cited by this paper
• Opiate receptors and beyond: 30 years of neural signaling research.

  2004cited by this paper
• Can coadministration of oxycodone and morphine produce analgesic synergy in humans? An experimental cold pain study.

  2004cited by this paper
• Opioid switching to improve pain relief and drug tolerability.

  2004cited by this paper
• Addition of a second opioid may improve opioid response in cancer pain: preliminary data

  2004cited by this paper
• Opioid combination for cancer pain

  2004cited by this paper
• Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients

  2003cited by this paper
• Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs.

  2002cited by this paper
• Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness.

  2001cited by this paper
• Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)

  2001cited by this paper
• Incomplete cross tolerance and multiple mu opioid peptide receptors.

  2001cited by this paper
• Co‐administration of sub‐antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side‐effects in rats

  2000cited by this paper
• An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain.

  1999cited by this paper
• Opioid rotation for cancer pain

  1999cited by this paper
• The intrinsic antinociceptive effects of oxycodone appear to be &kgr;‐opioid receptor mediated

  1997cited by this paper
• Controlled‐release oxycodone and morphine in cancer related pain

  1997cited by this paper
• Preliminary Data

  1980cited by this paper
• History and development of mixed opioid agonists, partial agonists and antagonists.

  1979cited by this paper

• Integrating pharmacokinetic modeling and wearable-derived physiological data to assess pain intensity in patients with advanced urologic cancer.

  2026cites this paper
• Efficacy of opioid combination versus single opioid for adult cancer pain: a protocol for systematic review and meta-analysis

  2024cites this paper
• Evaluation the Protective Effect of Withania somnifera Extract on the Level of Sex Hormone in Morphine Addicted Femal e Rats

  2022cites this paper
• Evaluation the Protective Effect of Withania somnifera Extract on the Level of Sex Hormone in Morphine Addicted Female Rats

  2022cites this paper
• Oxycodone for cancer-related pain.

  2022cites this paper
• Dual opioid analgesia

  2022cites this paper
• Oxycodone for cancer-related pain.

  2022cites this paper
• Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline

  2022cites this paper
• A Randomized Controlled Trial Evaluating the Analgesic Effect of the Combination of Methadone With Morphine for Cancer Related Pain

  2021cites this paper
• Opioid Treatments for Chronic Pain

  2020cites this paper
• Efficacy and Safety of Fentanyl Compared With Morphine among Adult Patients with Cancer: A Meta-Analysis

  2020cites this paper
• The Use of Low-Dose Methadone as Add-On to Regular Opioid Therapy in Cancer-Related Pain at End of Life: A National Swedish Survey in Specialized Palliative Care

  2020influential citation
• The efficacy of tapentadol prolonged release in the treatment of mixed cancer pain

  2018cites this paper
• Combined use of strong opioids for pain relief in CanCer patients-a prospeCtive randomized Comparative study

  2018cites this paper
• Oxycodone for cancer-related pain.

  2017cites this paper
• Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction

  2017cites this paper
• Opioids for cancer pain - an overview of Cochrane reviews.

  2017cites this paper
• Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication* Revisitando a metadona: farmacocinética, farmacodinâmica e uso clínico

  2015cites this paper
• Articles of interest in other scholarly journals

  2015cites this paper
• Pain management of the cancer patient

  2015cites this paper
• Pharmacological options for the management of refractory cancer pain—what is the evidence?

  2015cites this paper
• Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication

  2015cites this paper
• Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the study of pain and the Polish Neurological Society - part one.

  2014cites this paper
• Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the Study of Pain and the Polish Neurological Society - Part Two.

  2014cites this paper
• Efficacy and safety of dual opioid therapy

  2014cites this paper
• Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients.

  2014cites this paper
• Critical Appraisal of the Breakthrough Pain in Cancer

  2013cites this paper
• Addition of Methadone to Another Opioid in the Management of Moderate to Severe Cancer Pain: A Case Series

  2013cites this paper
• Combination pharmacotherapy for management of chronic pain: from bench to bedside.

  2013cites this paper
• Comparison of Pain Management between before and after the Application of Guidelines in Cancer Emergency Room

  2012cites this paper
• The Role of Opioid Analgesics in the Treatment of Pain in Cancer Patients

  2012cites this paper
• Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

  2012cites this paper
• Evidence from basic research for opioid combinations

  2012cites this paper
• Pain Conference and Practical Workshop

  2011cites this paper